News For Diagnostic Substances


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 9/22/2018 1:03:30 PM

Tuberculosis Diagnostics Market Analysis, Demand, Share, Growth Estimation, Developing Trends and Forecast 2023 - Port Herald News Now


Tuberculosis Diagnostics Market Analysis, Demand, Share, Growth Estimation, Developing Trends and Forecast 2023
Port Herald News Now
Global Tuberculosis Diagnostics market research report forecast 2023 shows an exhaustive assessment of the market and contains sharp bits of learning, substances, undeniable data, and quantifiably reinforced and industry approved market information.

and more »
Google 9/22/2018 4:55:00 AM

AI Designed with a “Sense of Smell” To Detect Illnesses from Human Breath - Evolving Science (blog)


Evolving Science (blog)

AI Designed with a “Sense of Smell” To Detect Illnesses from Human Breath
Evolving Science (blog)
The main aim of this AI was to diagnose whether a person could be ill or not. This fact has great potential as it also has the ability to detect and identify substances in the air. If machines such as these gain the capacity to identify an illness (and ...

Google 9/21/2018 4:53:30 PM

Navidea Biopharmaceuticals (NAVB) Shares Up -16.1% - Marea Informative (blog)


Marea Informative (blog)

Navidea Biopharmaceuticals (NAVB) Shares Up -16.1%
Marea Informative (blog)
The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages; and NAV4694, a fluorine-18 ...

Google 9/21/2018 10:34:29 AM

Navidea Biopharmaceuticals Inc (NAVB) Short Interest Update - Fairfield Current


Fairfield Current

Navidea Biopharmaceuticals Inc (NAVB) Short Interest Update
Fairfield Current
The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages; and NAV4694, a fluorine-18 ...

and more »
Google 9/21/2018 10:33:12 AM

Navidea Biopharmaceuticals (NAVB) Shares Down 4% - Fairfield Current


Fairfield Current

Navidea Biopharmaceuticals (NAVB) Shares Down 4%
Fairfield Current
The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages; and NAV4694, a fluorine-18 ...

and more »
Google 9/20/2018 6:23:18 PM

Must Read that What Makes a Stock Risky?: Palatin Technologies (PTN) - Wallstreet Investorplace


Wallstreet Investorplace

Must Read that What Makes a Stock Risky?: Palatin Technologies (PTN)
Wallstreet Investorplace
Palatin Technologies is a part of Healthcare sector and belongs to Diagnostic Substances industry. The recent session has given its stock price a 78.82% positive lead over its 52-week low and showed downward move of -35.22% over its 52-week high.

and more »
Google 9/20/2018 4:14:07 PM

Short Interest in Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) Drops By 2.7% - Fairfield Current


Fairfield Current

Short Interest in Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) Drops By 2.7%
Fairfield Current
The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages; and NAV4694, a fluorine-18 ...

and more »
Google 9/18/2018 10:27:03 PM

 1 2